Stakeholder Evidence Requirements and Price Expectations for Biosimilars in Three Asian Markets. | Value Health;17(7): A775-6, 2014 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Stakeholder Evidence Requirements and Price Expectations for Biosimilars in Three Asian Markets.

Akpinar, P; Saraf, S; Severi Bruni, D; Li, X; Liu, C; Sherwin, G.

Affiliation

Akpinar P; ICON Pricing and Market Access, London, UK.
Saraf S; ICON Pricing and Market Access, London, UK.
Severi Bruni D; ICON Pricing and Market Access, San Francisco, CA, USA.
Li X; ICON Commercialisation & Outcomes, London, UK.
Liu C; ICON Pricing and Market Access, New York, NY, USA.
Sherwin G; ICON Pricing and Market Access, London, UK.

Value Health ; 17(7): A775-6, 2014 Nov.

Article in En | MEDLINE | ID: mdl-27202867

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Country of publication: United States